High TLR2 and TLR4 expression during anti-tuberculosis treatment associated with a moderate form of disease suggests that these receptors were seems likely beneficial to the patients because such TLRs can induce the production of pro-inflammatory cytokines. The gene discussed is TLR4; the disease is tuberculosis.